Amneal to Report Third Quarter 2022 Results on November 4, 2022
10/06/2022 - 08:00 AM
BRIDGEWATER, N.J. --(BUSINESS WIRE)--
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2022 financial results on Friday November 4, 2022 , prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on November 4, 2022 .
The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com .
To access the call through a conference line, dial 1 (844) 200-6205 (in the U.S. ) or 1 (929) 526-1599 (international callers). The access code for the call is 585341.
A replay of the conference call will be posted shortly after the call and will be available for seven days. To access the replay, dial 1 (866) 813-9403 (in the U.S. ) or +44 (204) 525-0658 (international callers). The access code for the replay is 049751.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ , is a fully integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States . The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across a broad range of complex products and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceutical products focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more, please visit www.amneal.com .
View source version on businesswire.com : https://www.businesswire.com/news/home/20221006005069/en/
Anthony DiMeo
Anthony.DiMeo@amneal.com
Source: Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals Inc
AMRX Rankings
#238 Ranked by Stock Gains
AMRX Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Bridgewater
About AMRX
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
